Annual D&A
$638.70 M
+$9.22 M+1.47%
31 December 2023
Summary:
Jazz Pharmaceuticals annual depreciation & amortization is currently $638.70 million, with the most recent change of +$9.22 million (+1.47%) on 31 December 2023. During the last 3 years, it has risen by +$360.44 million (+129.54%). JAZZ annual D&A is now at all-time high.JAZZ Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$165.23 M
+$2.20 M+1.35%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly depreciation & amortization is currently $165.23 million, with the most recent change of +$2.20 million (+1.35%) on 30 September 2024. Over the past year, it has increased by +$2.67 million (+1.64%). JAZZ quarterly D&A is now -8.06% below its all-time high of $179.71 million, reached on 31 March 2022.JAZZ Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$650.85 M
+$2.67 M+0.41%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM depreciation & amortization is currently $650.85 million, with the most recent change of +$2.67 million (+0.41%) on 30 September 2024. Over the past year, it has increased by +$26.63 million (+4.27%). JAZZ TTM D&A is now -2.58% below its all-time high of $668.11 million, reached on 30 June 2022.JAZZ TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.5% | +1.6% | +4.3% |
| 3 y3 years | +129.5% | -1.4% | +41.6% |
| 5 y5 years | +194.7% | +147.2% | +168.3% |
JAZZ Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +129.5% | -8.1% | +14.2% | -2.6% | +41.6% |
| 5 y | 5 years | at high | +194.7% | -8.1% | +147.2% | -2.6% | +168.3% |
| alltime | all time | at high | >+9999.0% | -8.1% | +8412.7% | -2.6% | >+9999.0% |
Jazz Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $165.23 M(+1.3%) | $650.85 M(+0.4%) |
| June 2024 | - | $163.03 M(-0.2%) | $648.18 M(+0.5%) |
| Mar 2024 | - | $163.38 M(+2.6%) | $644.72 M(+0.9%) |
| Dec 2023 | $638.70 M(+1.5%) | $159.20 M(-2.1%) | $638.70 M(+2.3%) |
| Sept 2023 | - | $162.56 M(+1.9%) | $624.23 M(+2.2%) |
| June 2023 | - | $159.58 M(+1.4%) | $610.49 M(+0.6%) |
| Mar 2023 | - | $157.36 M(+8.7%) | $607.12 M(-3.6%) |
| Dec 2022 | $629.47 M(+13.9%) | $144.73 M(-2.8%) | $629.47 M(-3.1%) |
| Sept 2022 | - | $148.83 M(-4.7%) | $649.36 M(-2.8%) |
| June 2022 | - | $156.20 M(-13.1%) | $668.11 M(+1.3%) |
| Mar 2022 | - | $179.71 M(+9.2%) | $659.22 M(+19.3%) |
| Dec 2021 | $552.48 M(+98.6%) | $164.62 M(-1.8%) | $552.48 M(+20.2%) |
| Sept 2021 | - | $167.58 M(+13.8%) | $459.54 M(+26.4%) |
| June 2021 | - | $147.31 M(+101.9%) | $363.45 M(+28.0%) |
| Mar 2021 | - | $72.97 M(+1.8%) | $283.85 M(+2.0%) |
| Dec 2020 | $278.25 M(-24.8%) | $71.67 M(+0.2%) | $278.25 M(-27.6%) |
| Sept 2020 | - | $71.49 M(+5.6%) | $384.53 M(+1.2%) |
| June 2020 | - | $67.71 M(+0.5%) | $379.89 M(+0.7%) |
| Mar 2020 | - | $67.37 M(-62.1%) | $377.11 M(+1.9%) |
| Dec 2019 | $370.16 M(+70.8%) | $177.95 M(+166.2%) | $370.16 M(+52.6%) |
| Sept 2019 | - | $66.85 M(+3.0%) | $242.62 M(+7.0%) |
| June 2019 | - | $64.93 M(+7.5%) | $226.66 M(+2.8%) |
| Mar 2019 | - | $60.42 M(+19.9%) | $220.43 M(+1.7%) |
| Dec 2018 | $216.73 M(+31.2%) | $50.41 M(-0.9%) | $216.73 M(-2.8%) |
| Sept 2018 | - | $50.90 M(-13.3%) | $223.02 M(+0.2%) |
| June 2018 | - | $58.69 M(+3.5%) | $222.50 M(+15.2%) |
| Mar 2018 | - | $56.73 M(+0.0%) | $193.09 M(+16.9%) |
| Dec 2017 | $165.15 M(+45.2%) | $56.70 M(+12.6%) | $165.15 M(+19.5%) |
| Sept 2017 | - | $50.38 M(+72.1%) | $138.24 M(+17.7%) |
| June 2017 | - | $29.28 M(+1.7%) | $117.43 M(+0.0%) |
| Mar 2017 | - | $28.80 M(-3.3%) | $117.41 M(+3.2%) |
| Dec 2016 | $113.78 M(+5.3%) | $29.78 M(+0.7%) | $113.78 M(+3.0%) |
| Sept 2016 | - | $29.57 M(+1.1%) | $110.44 M(+0.8%) |
| June 2016 | - | $29.25 M(+16.2%) | $109.54 M(+3.0%) |
| Mar 2016 | - | $25.17 M(-4.8%) | $106.32 M(-1.6%) |
| Dec 2015 | $108.06 M | $26.44 M(-7.8%) | $108.06 M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $28.68 M(+10.2%) | $115.65 M(-3.2%) |
| June 2015 | - | $26.03 M(-3.3%) | $119.47 M(-6.7%) |
| Mar 2015 | - | $26.91 M(-20.9%) | $128.10 M(-4.2%) |
| Dec 2014 | $133.68 M(+62.8%) | $34.04 M(+4.7%) | $133.68 M(+10.3%) |
| Sept 2014 | - | $32.50 M(-6.2%) | $121.15 M(+11.0%) |
| June 2014 | - | $34.66 M(+6.7%) | $109.11 M(+15.5%) |
| Mar 2014 | - | $32.49 M(+51.1%) | $94.45 M(+15.1%) |
| Dec 2013 | $82.09 M(+10.6%) | $21.51 M(+5.1%) | $82.09 M(-1.1%) |
| Sept 2013 | - | $20.46 M(+2.3%) | $83.01 M(-2.0%) |
| June 2013 | - | $19.99 M(-0.7%) | $84.67 M(+5.0%) |
| Mar 2013 | - | $20.13 M(-10.2%) | $80.66 M(+8.7%) |
| Dec 2012 | $74.23 M(+848.4%) | $22.43 M(+1.4%) | $74.23 M(+38.0%) |
| Sept 2012 | - | $22.12 M(+38.4%) | $53.78 M(+60.1%) |
| June 2012 | - | $15.98 M(+16.7%) | $33.59 M(+71.7%) |
| Mar 2012 | - | $13.70 M(+594.3%) | $19.56 M(+149.9%) |
| Dec 2011 | $7.83 M(-10.1%) | $1.97 M(+1.6%) | $7.83 M(-0.8%) |
| Sept 2011 | - | $1.94 M(-0.3%) | $7.89 M(-1.4%) |
| June 2011 | - | $1.95 M(-1.0%) | $8.00 M(-3.9%) |
| Mar 2011 | - | $1.97 M(-3.4%) | $8.32 M(-4.5%) |
| Dec 2010 | $8.71 M(-4.2%) | $2.04 M(-0.7%) | $8.71 M(-3.8%) |
| Sept 2010 | - | $2.05 M(-9.6%) | $9.06 M(-3.9%) |
| June 2010 | - | $2.27 M(-3.8%) | $9.43 M(+0.8%) |
| Mar 2010 | - | $2.36 M(-1.0%) | $9.35 M(+2.8%) |
| Dec 2009 | $9.10 M(-39.5%) | $2.38 M(-1.6%) | $9.10 M(-13.6%) |
| Sept 2009 | - | $2.42 M(+10.5%) | $10.53 M(-13.7%) |
| June 2009 | - | $2.19 M(+4.2%) | $12.20 M(-15.7%) |
| Mar 2009 | - | $2.10 M(-44.9%) | $14.48 M(-3.6%) |
| Dec 2008 | $15.03 M(+42.8%) | $3.81 M(-7.0%) | $15.03 M(+8.2%) |
| Sept 2008 | - | $4.10 M(-8.4%) | $13.88 M(+11.9%) |
| June 2008 | - | $4.47 M(+69.1%) | $12.40 M(+17.6%) |
| Mar 2008 | - | $2.65 M(-0.9%) | $10.55 M(+0.2%) |
| Dec 2007 | $10.53 M(+2.1%) | $2.67 M(+1.8%) | $10.53 M(+34.0%) |
| Sept 2007 | - | $2.62 M(+0.2%) | $7.86 M(+50.0%) |
| June 2007 | - | $2.61 M(-0.4%) | $5.24 M(+99.6%) |
| Mar 2007 | - | $2.62 M | $2.62 M |
| Dec 2006 | $10.31 M(+89.6%) | - | - |
| Dec 2005 | $5.44 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual D&A year-on-year change?
- What is Jazz Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly D&A year-on-year change?
- What is Jazz Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM D&A year-on-year change?
What is Jazz Pharmaceuticals annual depreciation & amortization?
The current annual D&A of JAZZ is $638.70 M
What is the all time high annual D&A for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual depreciation & amortization is $638.70 M
What is Jazz Pharmaceuticals annual D&A year-on-year change?
Over the past year, JAZZ annual depreciation & amortization has changed by +$9.22 M (+1.47%)
What is Jazz Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of JAZZ is $165.23 M
What is the all time high quarterly D&A for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly depreciation & amortization is $179.71 M
What is Jazz Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, JAZZ quarterly depreciation & amortization has changed by +$2.67 M (+1.64%)
What is Jazz Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of JAZZ is $650.85 M
What is the all time high TTM D&A for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM depreciation & amortization is $668.11 M
What is Jazz Pharmaceuticals TTM D&A year-on-year change?
Over the past year, JAZZ TTM depreciation & amortization has changed by +$26.63 M (+4.27%)